title: Reversal of alexia in multiple sclerosis by weak electromagnetic fields.
abstract: The occurrence of cognitive deficits in patients with multiple sclerosis (MS) has been recognized since 1877 when Charcot first observed "enfeeblement of memory" in his patients. Cognitive deficits have been reported in almost 50% of patients with a relapsing-remitting course and in a significantly higher percentage of patients with a chronic progressive course leading to intellectual disability which is often severe enough to preclude employment. MS is considered a form of subcortical dementia and the occurrence of classical cortical disorders such as aphasia, agnosia and apraxia is reported to be rare in the disease. However, in my experience alexia, a reading impairment unrelated to visual acuity or visual field defects, is common in patients with MS. Recently, I reported that treatment with picotesla range electromagnetic fields (EMFs) is an efficacious modality in the management of both the motor and cognitive symptoms of MS. Three patients with MS who developed alexia as a manifestation of the disease are presented. In all patients the alexia was reversed several months after they began treatment with EMFs. Since alexia usually reflects a disconnection syndrome whereby lesions involving the left visual cortex and the splenium of the corpus callosum disconnect language association areas from visual association areas, it is suggested that reversal of the alexia in these patients by EMFs was related to improved interhemispheric transcallosal transmission of visual information. In addition, it is conceivable that changes in the metabolism of monoamines, which are involved in visual information processing and reading comprehension, may have been important in causing reversal of the alexia. This report further supports the unique efficacy of this treatment modality in reversing specific cognitive deficits in MS.
authors: NeuroCommunication Research Laboratories, Danbury, CT 06811, USA.
authors: R
authors: R
authors: Sandyk
mesh_terms: D000328:Adult; D001921:Brain / Q000503:physiopathology; D004411:Dyslexia, Acquired / Q000209:etiology* / Q000628:therapy*; D004574:Electromagnetic Fields; D005260:Female; D006801:Humans; D008280:Magnetics; D008550:Melatonin / Q000378:metabolism; D008875:Middle Aged; D009103:Multiple Sclerosis / Q000150:complications* / Q000503:physiopathology; D010870:Pineal Gland / Q000378:metabolism
chemical_list: D008550:Melatonin